NanoViricides
NNVC
#10049
Rank
NZ$41.57 M
Marketcap
NZ$1.93
Share price
-0.88%
Change (1 day)
-14.39%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): NZ-$1.03

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$1.04. an increase over its 2024 EPS that were of NZ-$1.19.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025NZ-$1.07-10%
2024NZ-$1.19-5.41%
2023NZ-$1.265.71%
2022NZ-$1.19-13.58%
2021NZ-$1.38-66.11%
2020NZ-$4.071.7%
2019NZ-$4.00-10.98%
2018NZ-$4.50-22.35%
2017NZ-$5.79-10.53%
2016NZ-$6.47375%
2015NZ-$1.36-85.19%
2014NZ-$9.2042.11%
2013NZ-$6.4726.67%
2012NZ-$5.11-6.25%
2011NZ-$5.4514.28%
2010NZ-$4.77100%
2009NZ-$2.39-0%
2008NZ-$2.39-33.33%
2007NZ-$3.58-0%
2006NZ-$3.584445.07%
2005NZ-$0.07873

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ$11.11-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.45-1,297.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.06-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.42-717.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$3.61-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$0.08519-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA